Racemose neurocysticercosis after chronic meningitis: effect of medical treatment.
A patient affected by racemous neurocysticercosis, occurring 5 years after the onset of chronic meningitis and followed by sequential MRI studies, is described. After ventriculo-peritoneal shunt, he was successfully treated with Praziquantel and Albendazole. This case may contribute to understand the natural history of the disease and stress the efficacy of medical versus surgical treatment of this lifethreatening disease.
La Mantia
L
L
Department of Neurology, Instituto Nazionale Neurologico C. Besta, Milano, Italy.
Costa
A
A
Eoli
M
M
Savoiardo
M
M
D000328:Adult; D015766:Albendazole / Q000627:therapeutic use*; D002908:Chronic Disease; D003551:Cysticercosis / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008581:Meningitis / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D009460:Neurologic Examination; D011223:Praziquantel / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D017287:Ventriculoperitoneal Shunt
D011223:Praziquantel; D015766:Albendazole